---
annotations:
- id: DOID:1793
  parent: disease of cellular proliferation
  type: Disease Ontology
  value: pancreatic cancer
authors:
- Mbaardwijk
- Eweitz
description: Molecular Targets for the treatment  of pancreatic cancer
last-edited: 2021-06-05
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP5080
- /instance/WP5080
revision: null
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP5080.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Molecular Targets for the treatment  of pancreatic cancer
  keywords:
  - ''
  - AMG479
  - AZD6244
  - Akt
  - Axitinib
  - BKM120
  - Bevacizumab
  - Cell growth
  - Cytokine
  - Cyyokine
  - Dosatinib
  - EGFR
  - ERK
  - Erotinib
  - Everolimus
  - Foretinib
  - IGF-1R
  - Integrin
  - JAK
  - MEK
  - Metabolism
  - Metaformin
  - Metastasis
  - Nimotuzumab
  - Nintedanib
  - PI3K
  - PTEN
  - RAF
  - RAS-GDP
  - RAS-GTP
  - RX-0201
  - Resistance to chemotherapy
  - SKLB2261
  - SKLB261
  - SRC
  - STAT
  - Sorafenib
  - Survival
  - Tyk
  - VEGF
  - VEGFR
  - mTOR
  - receptor
  - ruxolitinib
  - trametinib
  license: CC0
  name: Molecular targets for treatment of pancreatic cancer
seo: CreativeWork
title: Molecular targets for treatment of pancreatic cancer
wpid: WP5080
---